fah hospital policy blog

This morning the leaders of seven major pharmaceutical companies are going to testify before the Senate Finance Committee. It is widely expected that they will downplay their role in the out-of-control price increases for lifesaving drugs needed by American families.

The Federation of American Hospitals along with the American Hospital Association (AHA) and the American Society of Health-System Pharmacists (ASHP) held a briefing on Capitol Hill this week to present the findings from a recent joint study on drug pricing.

Today, the Federation of American Hospitals (FAH), the American Hospital Association (AHA), and the American Society of Health-System Pharmacists (ASHP) released a new report finding that continued rising drug prices, as well as shortages for many critical medications, are impacting patient care and putting strains on hospital budgets and operations. The report was prepared based on analysis conducted by NORC at the University of Chicago, an independent research institution.

The DC Federal District Court’s ruling to stop reforms to Medicare payment for drugs acquired under the 340B drug discount program is unfortunate because it undermines HHS efforts to cut drug costs and promote fairer payments.